|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.2 USD | -2.45% |
|
+4.10% | +6.77% |
| Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
| Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
Jan 25 (Reuters) - Moderna Inc said on Monday its COVID-19 vaccine produced virus-neutralizing antibodies against new variants of COVID-19 found in the UK and South Africa.
A two-dose regimen of the Moderna COVID-19 vaccine is expected to be protective against emerging strains detected to date, the company said. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,927 PTS | +0.00% | +0.64% | - | ||
| 451.1 PTS | +0.78% | -0.83% | - | ||
| 153.1 PTS | +0.29% | +0.35% | - | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +6.77% | 40.65B | |
| +1.12% | 42.59B | |
| +45.26% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B | |
| -18.79% | 9.85B |
MODERNA, INC. 
